MONTREAL, Oct. 31, 2019 /PRNewswire/ - (NYSE: CAE) (TSX: CAE) – CAE will release its fiscal year 2020 second quarter results on Wednesday, November 13, 2019. A conference call will be held on the same day at 1 p.m. Eastern Time (ET) to provide analysts and institutional investors with a review of CAE's per

NESS ZIONA, Israel, Nov. 11, 2019 /PRNewswire/ -- Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company, today announced that it will present the interim results of Cohort A of its ongoing Phase 1/2a Clinical Trial in ALS (as published in

Dr. Kerklaan Therapeutics amongst the first CBD products to be on shelves at Selfridges, DFS North America, Dillard's and Lord + Taylor LOS ANGELES, Nov. 8, 2019 /PRNewswire/ -- Dr. Kerklaan Therapeutics (

SUZHOU, China, Nov. 11, 2019 /PRNewswire/ -- TenNor Therapeutics reported positive top-line results for TNP-2092 powder for injection from a phase II clinical trial conducted in the United States. TNP-2092 is currently under clinical development for the treatment of prosthetic joint

ATLANTA, Nov. 11, 2019 /PRNewswire/ -- At the 2019 American College of Rheumatology/Association of Rheumatology Professionals annual meeting in Atlanta, experts from the HSS Education Institute at Hospital for Special Surgery (HSS) presented their method for developing and implementing effective educational programs for diverse patients w

VIMOVO Litigation to Continue MISSISSAUGA, ON, Nov. 11, 2019 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced that the United States District Court

SAN FRANCISCO, Nov. 11, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to a

DUBLIN, Nov. 11, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the U.S. Food and Drug Administration (FDA) has granted Qualified Infectious Disease Product (QIDP) Designation and Fast Track Designation for ATM-AVI (aztreonam and avibactam), for the treatment of complicated intra-abdominal infections (cIAI), complicated urinary tract infections (cUTI)

DENVER, Nov. 11, 2019 /PRNewswire/ -- Medicine Man Technologies, Inc. (OTCQX: MDCL) ("Medicine Man Technologies" or the "Company") today announced the financial results for its third quarter of 2019.

SANTA CLARA, Calif., Nov. 11, 2019 /PRNewswire/ -- Healthcare has evolved from a procedure volume-driven system to quality medicine and outcome-based system. If the focus is on improving the quality of outcomes and the health of a defined population, the cost per capita for delivering care will reduce. In line with this need, many physicians from different special